Clovis Oncology, Inc. (CLVSQ) vs Vyome Holdings, Inc. (HIND)
- Clovis Oncology, Inc. CLVSQ
- Vyome Holdings, Inc. HIND 1.87 −2.09%
Clovis Oncology, Inc. and Vyome Holdings, Inc. are both Biotechnology companies. Clovis Oncology, Inc. and Vyome Holdings, Inc. are of similar size ($14.2M and $13.4M). Clovis Oncology, Inc. has negative trailing earnings, so its P/E is not meaningful; Vyome Holdings, Inc. trades at 0.0×. Vyome Holdings, Inc. grew revenue faster over the last twelve months: 103.8% against −14.8%. Clovis Oncology, Inc. has the higher net margin (−189.4% vs −8,711.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Clovis Oncology, Inc. leads on 11 and Vyome Holdings, Inc. on 5.
Valuation
Profitability
| Metric | CLVSQ | HIND | Biotechnology median |
|---|---|---|---|
| Gross margin | 72.21% | 52.77% | 65.16% |
| Operating margin | (155.38%) | (9,184.82%) | 0.00% |
| Net margin | (189.37%) | (8,711.71%) | 0.00% |
| Free cash flow margin | (132.19%) | (4,298.00%) | 0.00% |
| Return on equity | 78.31% | (172.10%) | (56.36%) |
| Return on assets | (58.94%) | (124.23%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack